Global Cardiopulmonary Bypass Equipment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Single Roller Pump and Double Roller Pump.

By End Users;

Hospitals and Ambulatory Surgical Centers.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn530847204 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Cardiopulmonary Bypass Equipment Market (USD Million), 2021 - 2031

In the year 2024, the Global Cardiopulmonary Bypass Equipment Market was valued at USD 2,033.33 million. The size of this market is expected to increase to USD 2,946.09 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.4%.

The global cardiopulmonary bypass equipment market stands as a critical pillar in modern healthcare, providing essential support for patients undergoing complex cardiac surgeries. This market encompasses a wide array of sophisticated devices and technologies designed to facilitate cardiopulmonary bypass (CPB), a process where a patient's heart and lungs are temporarily bypassed during surgery, allowing surgeons to perform intricate procedures with precision and safety. With the rising prevalence of cardiovascular diseases worldwide, the demand for cardiopulmonary bypass equipment continues to escalate, driving innovation and advancements in the field.

One of the key factors fueling the growth of the global cardiopulmonary bypass equipment market is the increasing incidence of cardiovascular ailments, including coronary artery disease, heart valve disorders, and congenital heart defects. As the aging population expands and lifestyle factors contribute to the prevalence of cardiac conditions, the need for cardiac surgeries and interventions rises, propelling the demand for sophisticated CPB equipment. Moreover, technological advancements have led to the development of more efficient and safer bypass systems, further spurring market growth.

The evolving landscape of cardiac surgery, characterized by a shift towards minimally invasive procedures and hybrid approaches, presents new opportunities for innovation within the cardiopulmonary bypass equipment market. Manufacturers are focusing on enhancing the functionality and compatibility of CPB devices with minimally invasive techniques, enabling surgeons to perform complex procedures with reduced trauma and improved patient outcomes. Additionally, growing awareness regarding the benefits of early intervention and timely cardiac surgeries is expected to contribute to market expansion, particularly in emerging economies where access to advanced medical care is improving.

Despite the promising growth prospects, the global cardiopulmonary bypass equipment market faces challenges such as stringent regulatory requirements, high costs associated with advanced equipment, and the risk of complications during CPB procedures. Addressing these challenges necessitates collaboration between industry stakeholders, healthcare providers, and regulatory bodies to ensure the safe and effective use of cardiopulmonary bypass equipment. Moreover, efforts to enhance affordability and accessibility, particularly in developing regions, will be crucial for ensuring equitable healthcare delivery and driving sustained market growth.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By End Users
    3. Market Snapshot, By Region
  4. Global Cardiopulmonary Bypass Equipment Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing prevalence of cardiovascular diseases
        2. Technological advancements
        3. Aging population
        4. Growing demand for minimally invasive procedures
        5. Rising healthcare expenditure
      2. Restraints
        1. High cost of equipment
        2. Stringent regulatory requirements
        3. Complications associated with bypass procedures
        4. Limited reimbursement policies
        5. Alternatives to bypass surgery
      3. Opportunities
        1. Emerging markets
        2. Development of hybrid operating rooms
        3. Focus on product innovation
        4. Collaborations and partnerships
        5. Increasing awareness and education
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Cardiopulmonary Bypass Equipment Market, By Product Type, 2021 - 2031 (USD Million)
      1. Single Roller Pump
      2. Double Roller Pump
    2. Global Cardiopulmonary Bypass Equipment Market, By End Users, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ambulatory Surgical Centers
    3. Global Cardiopulmonary Bypass Equipment Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Medtronic plc
      2. LivaNova PLC
      3. Terumo Corporation
      4. Getinge AB
      5. Braile Biomedica
      6. Sorin Group
      7. Maquet (a subsidiary of Getinge AB)
      8. Xenios AG
      9. MicroPort Scientific Corporation
      10. SynCardia Systems, LLC
  7. Analyst Views
  8. Future Outlook of the Market